Tracking lupus treatment in real life: does new drug deliver lasting relief?

NCT ID NCT05637112

Summary

This study follows 551 people with systemic lupus erythematosus (SLE) who are starting treatment with the drug anifrolumab in their regular doctor's offices. The goal is to see how well the drug controls lupus symptoms and improves quality of life over up to five years in real-world settings, outside of a controlled clinical trial. Researchers will track disease activity, flares, organ damage, and how patients feel day-to-day.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS ERYTHEMATOSUS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Innsbruck, Tyrol, 6020, Austria

  • Research Site

    Linz, Upper Austria, 4020, Austria

  • Research Site

    Vienna, 1180, Austria

  • Research Site

    Liège, Li Ge, 4000, Belgium

  • Research Site

    Aalst, Oost-Vlaanderen, 9300, Belgium

  • Research Site

    Bruges, West Flanders, 8000, Belgium

  • Research Site

    Leuven, 3000, Belgium

  • Research Site

    Calgary, Alberta, T2N 4N1, Canada

  • Research Site

    Winnipeg, Manitoba, RR149, Canada

  • Research Site

    Hamilton, Ontario, L8N 3Z5, Canada

  • Research Site

    Orillia, Ontario, L3V 1T5, Canada

  • Research Site

    Toronto, Ontario, M5T 2S9, Canada

  • Research Site

    Rimouski, Quebec, G5L 5T1, Canada

  • Research Site

    Sherbrooke, Quebec, J1G 2E8, Canada

  • Research Site

    Ste-Foy, Quebec, G1V 4G2, Canada

  • Research Site

    Nice, Alpes-Maritimes, 6000, France

  • Research Site

    Clermont-Ferrand, Auvergne-Rh ne-Alpes, 63000, France

  • Research Site

    Strasbourg, Bas-Rhin, 67098, France

  • Research Site

    Finist Re, Brest Cedex, 29609, France

  • Research Site

    Dijon, C te-d'Or, 21079, France

  • Research Site

    Bordeaux, Gironde, 33076, France

  • Research Site

    Grenoble, Is Re, 38043, France

  • Research Site

    Saint-Denis, La R Union, 97405, France

  • Research Site

    Nantes, Loire-Atlantique, 44093, France

  • Research Site

    Bouches-du-Rh Ne, Lyon, 69003, France

  • Research Site

    FORT de France Cedex, Martinique, 97261, France

  • Research Site

    Lille, Nord, 59037, France

  • Research Site

    Seine-Maritime, Rouen, 76230, France

  • Research Site

    Paris, 14033, France

  • Research Site

    Paris, 75013, France

  • Research Site

    Paris, 75014, France

  • Research Site

    Paris, 75020, France

  • Research Site

    Paris, 75475, France

  • Research Site

    Heidelberg, Baden-W Rttemberg, 69120, Germany

  • Research Site

    Heidelberg, Baden-Wurttemberg, 69120, Germany

  • Research Site

    Erlangen, Bavaria, 91054, Germany

  • Research Site

    Bad Bramstedt, Hamburg, 24576, Germany

  • Research Site

    Schleswig-Holstein, L Beck, 23562, Germany

  • Research Site

    Greifswald, Mecklenburg-Vorpommern, 17493, Germany

  • Research Site

    Munich, Monachium, 81925, Germany

  • Research Site

    Cologne, North Rhine-Westphalia, 51149, Germany

  • Research Site

    D Sseldorf, North Rhine-Westphalia, 40225, Germany

  • Research Site

    Herne, North Rhine-Westphalia, 44649, Germany

  • Research Site

    Mainz A. Rhein, Rhineland-Palatinate, 55131, Germany

  • Research Site

    Magdeburg, Saxony-Anhalt, 39104, Germany

  • Research Site

    Greifwald, Vorpommern-Greifswald, 17489, Germany

  • Research Site

    Berlin, 10117, Germany

  • Research Site

    Kfar Saba, Central District, 4428164, Israel

  • Research Site

    Tel Hashomer, Central District, 5211401, Israel

  • Research Site

    Tiberias, Galilee, 15208, Israel

  • Research Site

    Haifa, Haifa District, 3109601, Israel

  • Research Site

    Haifa, Haifa District, 3436212, Israel

  • Research Site

    Jerusalem, Jerusalem, 91120, Israel

  • Research Site

    Afula, Northern District, 18101, Israel

  • Research Site

    Ramat Gan, Tel Aviv, 52621, Israel

  • Research Site

    Tel Aviv, Tel Aviv, 6423906, Israel

  • Research Site

    Napoli, Campania, 80131, Italy

  • Research Site

    Cona, Emilia-Romagna, 44124, Italy

  • Research Site

    Udine, Friuli Venezia Giulia, 33100, Italy

  • Research Site

    Rome, Lazio, 149, Italy

  • Research Site

    Brescia, Lombardy, 25100, Italy

  • Research Site

    Milan, Lombardy, 20122, Italy

  • Research Site

    Turin, Piedmont, 10126, Italy

  • Research Site

    Cagliari, Sardinia, 9042, Italy

  • Research Site

    Ancona, 60126, Italy

  • Research Site

    Bari, 70124, Italy

  • Research Site

    Florence, 50134, Italy

  • Research Site

    Milan, 20122, Italy

  • Research Site

    Milan, 20132, Italy

  • Research Site

    Pisa, 56126, Italy

  • Research Site

    Roma, 161, Italy

  • Research Site

    Roma, 168, Italy

  • Research Site

    Örebro, N Rke, 70185, Sweden

  • Research Site

    Danderyd, Stockholm County, 18288, Sweden

  • Research Site

    Stockholm, Uppland, 171 76, Sweden

  • Research Site

    Dubai, Dubayy, 7272, United Arab Emirates

  • Research Site

    Dubai, Dubayy, United Arab Emirates

  • Research Site

    Sharjah city, Emirate of Sharjah, 72772, United Arab Emirates

  • Research Site

    Abu Dhabi, United Arab Emirates

Conditions

Explore the condition pages connected to this study.